血漿交換市場規模、佔有率、成長分析、按產品、按技術、按程序、按應用、按最終用戶、按地區 - 行業預測，2025-2032 年

2023年血漿交換市場規模為12.4億美元，從2024年的13.4億美元成長到2032年的24.1億美元，複合年成長率預計為7.7%。

由於各種宏觀經濟和微觀經濟因素，全球血漿交換產業有望顯著成長。醫療保健支出的增加，特別是在中東和亞太地區，正在推動人們對先進醫療的日益關注。此外，人們對重症肌無力和狼瘡等免疫系統疾病治療方案的認知不斷提高，預計將推動市場需求。根據市場預估與預測，2022年至2028年該市場預計將成長約79bp，佔自體免疫疾病診斷產業的35.9%以上，預計複合年成長率為21.1%。預計將達到 12 億美元，到 2021年終將達到 13 億美元，複合年成長率為 4.6%，其中北美市場處於領先地位。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 宏觀經濟指標
• 價值鏈分析
• 價格分析

血漿交易市場規模：依產品分類

• 市場概況
• 裝置
• 一次性的

血漿交易市場規模：依技術分類

• 市場概況
• 薄膜過濾
• 離心

血漿交易市場規模：按程序

• 市場概況
• 照光治療
• 低密度脂蛋白單採術
• 血小板成分採集
• 白血球去除手術
• 紅血球去除療法

血漿交換市場規模：依應用分類

• 市場概況
• 血漿採集源
• 治療性血漿置換
• 免疫學
• 神經病學
• 血液學
• 加護治療
• 腫瘤學
• 風濕病學/整形外科
• 其他治療用途

血漿交換市場規模：依最終用戶分類

• 市場概況
• 血庫和血漿採集中心
• 醫院/診所
• 生物製藥公司
• 其他最終用戶

血漿交易所市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2022-2024）

主要企業簡介

• CSL Limited（Australia）
• Takeda Pharmaceutical Company Limited（Japan）
• Grifols, SA（Spain）
• Baxter International Inc.（United States）
• Kedrion SpA（Italy）
• Octapharma AG（Switzerland）
• Asahi Kasei Medical Co., Ltd.（Japan）
• B. Braun Melsungen AG（Germany）
• Fresenius SE & Co. KGaA（Germany）
• Terumo BCT, Inc.（United States）
• Haemonetics Corporation（United States）
• Cerus Corporation（United States）
• Nikkiso Co., Ltd.（Japan）
• Kawasumi Laboratories, Inc.（Japan）
• Macopharma SA（France）
• Shanghai RAAS Blood Products Co., Ltd.（China）
• China Biologic Products Holdings, Inc.（China）
• LFB SA（France）
• Bio Products Laboratory Ltd.（United Kingdom）
• Sanquin Blood Supply Foundation（Netherlands）

結論和建議

Plasmapheresis Market size was valued at USD 1.24 Billion in 2023 and is poised to grow from USD 1.34 Billion in 2024 to USD 2.41 Billion by 2032, growing at a CAGR of 7.7% during the forecast period (2025-2032).

The global plasmapheresis industry is poised for significant growth due to a variety of macroeconomic and microeconomic factors. Increased healthcare spending, particularly in the Middle East and Asia-Pacific regions, is driving a greater focus on advanced medical therapies. Additionally, heightened awareness of treatment options for immune system disorders such as myasthenia gravis and lupus is expected to fuel market demand. Projections indicate a growth of approximately 79 basis points from 2022 to 2028, with the market catering to over 35.9% of the autoimmune disease diagnostics sector, which is estimated to grow at a 21.1% CAGR. The market experienced a 4.6% CAGR increase to reach USD 1.2 billion by the end of 2021 and is anticipated to reach USD 1.3 billion, with North America leading the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Plasmapheresis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Plasmapheresis Market Segmental Analysis

Global Plasmapheresis Market is segmented by product, technology, procedure, application, end user and region. Based on product, the market is segmented into instruments and disposables. Based on technology, the market is segmented into membrane filtration and centrifugation. Based on procedure, the market is segmented into photopheresis, Ldl apheresis, plateletpheresis, leukapheresis and erythrocytapheresis. Based on application, the market is segmented into source plasma collection, therapeutic plasmapheresis, immunology, neurology, hematology, critical care, oncology, rheumatology & orthopedics and other therapeutic applications. Based on end user, the market is segmented into blood banks & plasma collection centers, hospital & clinics, biopharmaceutical companies and other end user. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Plasmapheresis Market

The plasmapheresis market is poised for growth, largely driven by its critical role in managing a range of autoimmune disorders, including thrombotic thrombocytopenic purpura, Guillain-Barre syndrome, Myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. As the prevalence of these conditions rises, so does the demand for plasmapheresis equipment. Additionally, increasing awareness among end-users and a heightened focus on enhancing healthcare infrastructure are anticipated to propel market expansion. The growing healthcare investments in regions such as the Middle East, Africa, and Asia Pacific are further expected to drive the adoption of advanced treatment methods, thereby boosting the plasmapheresis industry during the forecast period.

Restraints in the Plasmapheresis Market

The plasmapheresis market faces certain restraints primarily due to concerns regarding adverse effects associated with the procedure. Although these side effects, which can include decreased arterial blood pressure, arrhythmias, transient increases in body temperature, and paresthesia, are generally mild, they can still deter potential patients from opting for this therapy. Consequently, these safety concerns may hinder the overall adoption of plasmapheresis, impacting its growth in the market. As such, market players could experience challenges during the evaluation period due to a decline in the utilization of plasmapheresis as a viable treatment option, affecting their overall market performance.

Market Trends of the Plasmapheresis Market

The plasmapheresis market is poised for significant growth, fueled by the escalating demand for effective treatments for various ailments including anemia, blood disorders, and autoimmune diseases. Innovations in apheresis technology, driven by advancements in healthcare infrastructure and increased investments in research and development, are enhancing the efficiency and safety of plasmapheresis procedures. Furthermore, the rising awareness of the therapeutic benefits of plasma exchange therapies is catalyzing a surge in blood donation rates. As healthcare organizations focus on optimizing plasmapheresis equipment worldwide, the market is expected to expand robustly in the coming years, driven by these pivotal trends and advancements.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Plasmapheresis Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
• Disposables

Global Plasmapheresis Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Membrane Filtration
• Centrifugation

Global Plasmapheresis Market Size by Procedure & CAGR (2025-2032)

• Market Overview
• Photopheresis
• Ldl Apheresis
• Plateletpheresis
• Leukapheresis
• Erythrocytapheresis

Global Plasmapheresis Market Size by Application & CAGR (2025-2032)

• Market Overview
• Source Plasma Collection
• Therapeutic Plasmapheresis
• Immunology
• Neurology
• Hematology
• Critical Care
• Oncology
• Rheumatology & Orthopedics
• Other Therapeutic Applications

Global Plasmapheresis Market Size by End User & CAGR (2025-2032)

• Market Overview
• Blood Banks & Plasma Collection Centers
• Hospital & Clinics
• Biopharmaceutical Companies
• Other End User

Global Plasmapheresis Market Size & CAGR (2025-2032)

• North America (Product, Technology, Procedure, Application, End User)
  • US
  • Canada
• Europe (Product, Technology, Procedure, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Procedure, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Procedure, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Procedure, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• CSL Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols, S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kedrion S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Octapharma AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Medical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius SE & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo BCT, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemonetics Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerus Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikkiso Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kawasumi Laboratories, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macopharma SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai RAAS Blood Products Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• China Biologic Products Holdings, Inc. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LFB S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio Products Laboratory Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanquin Blood Supply Foundation (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations